Sugi Predict

Sugi Predict / Compounds / SCHEMBL857633

SCHEMBL857633

SCHEMBL857633

Fc1cccc2ncc[c]c12

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PARP1 P09874 1/20 0.33
▸ PDGFRB P09619 1/20 0.32
▸ PDGFRA P16234 1/20 0.32
▸ NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29266188 0.98 MAPT (0.33) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL4470271 0.76 ALDH1A1 (0.34) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL4467440 0.76 ALDH1A1 (0.35) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL5750689 0.72 TRIM24 (0.39) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL5750909 0.72 HTT (0.35) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL4461039 0.72 NQO2 (0.41) MAPTALDH1A1KDM4EPOLBPDGFRB
SCHEMBL5748471 0.72 GABRA1 (0.36) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL16742762 0.71 KDM4E (0.33) KDM4E
SCHEMBL5747005 0.69 PARP1 (0.44) MAPTALDH1A1KDM4EPARP1PDGFRA
SCHEMBL2514729 0.69 KDM4E (0.42) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113891879-A 3, 6-disubstituted-2-pyridine aldoxime skeletons 国家科学研究中心 2022-01-04 — — CN claimed
EP-3924334-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS Centre national de la recherche scientifique (FR) 2021-12-22 — — EP claimed
WO-2020165432-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-08-20 — — WO claimed
EP-3696170-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-08-19 — — EP claimed
CN-113891879-A 3, 6-disubstituted-2-pyridine aldoxime skeletons 国家科学研究中心 2022-01-04 — — CN disclosed
EP-3924334-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS Centre national de la recherche scientifique (FR) 2021-12-22 — — EP disclosed
WO-2020165432-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-08-20 — — WO disclosed
EP-3696170-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-08-19 — — EP disclosed
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-04-17 — — US disclosed
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 — — US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 — — US disclosed
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 — — EP disclosed
US-7521454-B2 Adenine derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-04-21 — — US disclosed
EP-1386923-B1 NOVEL ADENINE DERIVATIVES DAINIPPON SUMITOMO PHARMA CO (JP) 2008-08-13 — — EP disclosed
US-20070037832-A1 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-02-15 — — US disclosed
US-7157465-B2 Adenine derivatives DAINIPPON SIMITOMO PHARMA CO., LTD. (JP) 2007-01-02 — — US disclosed
CN-1250548-C Novel adenine derivatives SUMITOMO PHARMA (JP) 2006-04-12 — — CN disclosed
CN-1512992-A Novel adenine derivatives ס����ҩ��ʽ���� 2004-07-14 — — CN disclosed
US-20040132748-A1 Novel adenne derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-07-08 — — US disclosed
EP-1386923-A1 NOVEL ADENINE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132748-A1 Novel adenne derivatives IRF3, IFNAR1, STING1 MAPT 1548/4885ALDH1A1 1181/4885KDM4E 2790/4885
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA MAPT 1136/4885ALDH1A1 3533/4885KDM4E 361/4885
US-20070037832-A1 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis IRF3, IFNAR1, IFNG MAPT 859/4885ALDH1A1 2467/4885KDM4E 2317/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA MAPT 1639/4885ALDH1A1 3049/4885KDM4E 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.